Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Risk of death associated with nesiritide in patients with acutely decompensated heart failure.

Aaronson KD, Sackner-Bernstein J.

JAMA. 2006 Sep 27;296(12):1465-6. No abstract available.

PMID:
17003394
2.
3.

Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials.

Abraham WT, Trupp RJ, Jarjoura D.

Clin Cardiol. 2010 Aug;33(8):484-9. doi: 10.1002/clc.20793.

4.

Nesiritide is beneficial or harmful to patients with decompensated acute congestive heart failure.

Ma X, Sun F, Ma J.

Int J Cardiol. 2015;187:387-8. doi: 10.1016/j.ijcard.2015.03.287. Epub 2015 Mar 20. No abstract available.

PMID:
25841132
5.

Risk of death with nesiritide.

Burger AJ.

JAMA. 2005 Aug 24;294(8):897; author reply 898. No abstract available.

PMID:
16118377
6.

Nesiritide for acute decompensated heart failure: does the benefit justify the risk?

Sackner-Bernstein J, Aaronson KD.

Curr Cardiol Rep. 2007 May;9(3):187-93. Review.

PMID:
17470331
7.

Impact of nesiritide on renal function and mortality in patients suffering from heart failure.

Dontas ID, Xanthos T, Dontas I, Lelovas P, Papadimitriou L.

Cardiovasc Drugs Ther. 2009 Jun;23(3):221-33. doi: 10.1007/s10557-009-6167-6. Review.

PMID:
19252976
8.

Efficacy and safety of nesiritide in patients with acute decompensated heart failure.

DeWald TA, Hernandez AF.

Expert Rev Cardiovasc Ther. 2010 Feb;8(2):159-69. doi: 10.1586/erc.09.173. Review.

PMID:
20136602
9.

Nesiritide: trials and tribulations.

Arora RR.

J Cardiovasc Pharmacol Ther. 2006 Sep;11(3):165-9. Review.

PMID:
17056828
10.

[Nesiritide in heart failure: commercial success or therapeutic advance?].

Stampfli T, Perrier A.

Rev Med Suisse. 2006 Jan 25;2(50):295-8. Review. French.

PMID:
16503047
11.

The ASCEND-HF trial: an acute study of clinical effectiveness of nesiritide and decompensated heart failure.

Dandamudi S, Chen HH.

Expert Rev Cardiovasc Ther. 2012 May;10(5):557-63. doi: 10.1586/erc.12.31.

PMID:
22651831
12.

[Does nesiritide reduce dyspnea in decompensated heart failure?].

Bernardo WM, Moreira FT.

Rev Assoc Med Bras (1992). 2012 Jan-Feb;58(1):11-3. Review. Portuguese. No abstract available.

13.

Safety and efficacy of nesiritide for acute decompensated heart failure: recent literature and upcoming trials.

Hiestand B, Abraham WT.

Curr Cardiol Rep. 2007 May;9(3):182-6. Review.

PMID:
17470330
14.

Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.

Munger MA, Ng TM, Van Tassell BW.

Pharmacotherapy. 2007 May;27(5):619-25. Review.

PMID:
17461695
16.

Nesiritide: harmful or harmless?

Dorsch MP, Rodgers JE.

Pharmacotherapy. 2006 Oct;26(10):1465-78. Review.

PMID:
16999657
17.

Re: Critical review and recommendations for nesiritide use in the Emergency Department.

Levine M.

J Emerg Med. 2007 Feb;32(2):207-8; author reply 208-9. Epub 2007 Jan 22. No abstract available.

PMID:
17307636
18.

Short and long-term mortality with nesiritide.

Arora RR, Venkatesh PK, Molnar J.

Am Heart J. 2006 Dec;152(6):1084-90.

PMID:
17161057
19.
20.

Nesiritide--not verified.

Schreiner G.

N Engl J Med. 2005 Oct 6;353(14):1525-7; author reply 1525-7. No abstract available.

PMID:
16211709

Supplemental Content

Support Center